Skip to main content
. 2020 May 14;369:m1849. doi: 10.1136/bmj.m1849

Table 2.

Treatments after randomisation in patients in intention to treat population. Values are numbers (percentages)

Treatments SOC plus HCQ (n=75) SOC (n=75) Total (n=150)
Antiviral agents 47 (63) 48 (64) 95 (63)
 Arbidol 37 (49) 33 (44) 70 (47)
 Virazole 13 (17) 15 (20) 28 (19)
 Lopinavir–ritonavir 13 (17) 12 (16) 25 (17)
 Oseltamivir 8 (11) 9 (12) 17 (11)
 Entecavir 1 (1) 1 (1) 2 (1)
Antibiotics 32 (43) 27 (36) 59 (39)
Systemic glucocorticoid treatment 6 (8) 4 (5) 10 (7)

HCQ=hydroxychloroquine; SOC=standard of care.